Abstract. We have generated mice transgenic for a human multidrug resistance (MDR)3 mini-gene driven by a hamster vimentin promoter. The MDR3 gene encodes a P-Glycoprotein that resembles the mouse multidrug resistance 2 P-Glycoprotein shown to be involved in the translocation of the phospholipid phosphatidylcholine through the hepatocyte canalicular membrane (Smit et al., 1993. Cell. 75:451-462). The vimentin promoter drives expression of the MDR3 transgene in mesenchymal tissues and in the eye lens.We show here that the presence of human multidrug resistance 3 P-Glycoprotein in the lens results in a severe lenticular pathology. Lens structural abnormalities initiate at a late embryonic stage and increase during postnatal lens development. Differentiation of the primary fibers is affected, and the terminal differentiation of the lens epithelium into secondary fibers is also perturbed. The ultrastructural alterations, particularly of the lens plasma membranes, resemble those identified in congenital mouse osmotic cataract. p -GLYCOPROTEINS (pgp)l are highly conserved membrane proteins that can function as ATP-dependent efflux pumps (23,31,57). They belong to the family of ATP-binding cassette transporter proteins (37). Two genes for Pgps have been identified in humans: human multidrug resistance gene (MDR)I and MDR3 (also called MDR2 [10,72,73], and three in mice: mouse multidrug resistance gene (mdr)l (or mdrlb), mdr3 (or mdrla), and mdr2 (16,33,35).The human multidrug resistance (MDR)I Pgp (and the related murine mdrl and mdr3, and hamster pgpl and pgp2 Pgps), can extrude a wide range of hydrophobic drugs from mammalian cells (18,34,42,70 pounds may represent the main physiological function of these Pgps (60). Attempts to show that the human MDR3 or the closely related mouse mdr2 Pgp (91% identity at the amino acid level) can confer MDR have been negative thus far (5,35,58,73).To find a physiological function for this class of Pgps, we have generated mice that are either unable to make the mdr2 Pgp or overproduce the MDR3 Pgp in many tissues (64; Smit, J.J.M., F. Baas, J.E. Hoogendijk, G. Jansen, F. Jennekens, M.A. van der Valk, A.H. Schinkel, A.J.M. Berns, K. Nooter, and P. Borst, manuscript in preparation). Mice homozygous for a disrupted mdr2 gene develop liver disease. A detailed analysis of these mice has shown that the mouse mdr2 Pgp (and presumably therefore also its human MDR3 counterpart) is essential for translocating phosphatidylcholine through the hepatocyte canalicular membrane into the bile (64,65). This indicates that this Pgp is a specific phospholipid translocator, as has recently been supported by in vitro experiments (54, 66).We have generated mice containing an MDR3 minigene under the control of a vimentin promoter which drives the expression of the transgene in mesenchymal tissues and in the eye lens. These mice develop a peripheral neuropathy and microphthalmia. Here we present an analysis of the abnormalities in the lenticular cells of these